提高成人脊柱畸形手术成本效益:识别较低总费用的预测因素
3年总费用范围为57,606.88至116,312.54美元,平均72,947.87美元,不同畸形组间无显著差异。整体较低费用的预测因素包括衰弱评分<0.19、基线SRS活动评分>1.5、基线ODI<50。
要点
- 3年总费用范围57,606.88至116,312.54美元,平均72,947.87美元。
- 整体较低费用预测因素:衰弱评分<0.19、基线SRS活动>1.5、基线ODI<50。
- 不同SVA分级患者有各自的较低费用预测因素。
核心结论
- 成人脊柱畸形手术具有改善成本效益的潜力,3年总费用范围为57,606.88至116,312.54美元。
- 较低费用的预测因素包括较高的基线SRS活动评分、较低的衰弱评分以及无抑郁。
- 针对不同基线畸形特征识别了各自的较低费用预测因素,有助于优化所有患者的成本效益。
研究设计与样本
- 回顾性研究,基于前瞻性多中心数据库。
- 纳入标准:成人脊柱畸形手术患者,年龄>18岁,脊柱侧凸≥20°、矢状面垂直轴≥5 cm、骨盆倾斜≥25°或胸椎后凸≥60°。
- 费用计算使用PearlDiver数据库,并评估每质量调整生命年成本。
- 采用条件变量重要性表,基于20,000棵条件推断树的无替换抽样,识别与较低费用相关的首要因素。
主要发现
- 3年随访时,成人脊柱畸形手术的潜在费用范围为57,606.88至116,312.54美元。
- 3年平均手术费用为72,947.87美元,不同畸形组间费用无显著差异(P > 0.05)。
- 所有患者中,较低费用的首要预测因素为衰弱评分<0.19、基线SRS活动评分>1.5、基线ODI<50(均P < 0.05)。
- 低SVA患者中,无骨质疏松病史、SRS活动评分>1.5、年龄<64岁是较低费用的首要预测因素(均P < 0.05)。
- 中SVA患者中,ASD侵袭性评分<94.16、无癌症病史、衰弱评分<0.3呈较低总费用趋势(P = 0.071,P = 0.210)。
临床怎么用
- 对于成人脊柱畸形手术患者,可评估衰弱评分、基线SRS活动评分和ODI以识别可能费用较低的患者。
- 针对不同SVA分级,可参考相应的预测因素(如低SVA患者注意骨质疏松、年龄;高SVA患者注意吸烟和BMI)进行术前优化。
局限性
- 本研究为回顾性研究,证据等级为3级。
- 中SVA和高SVA组的预测因素仅呈趋势(P值分别为0.071、0.210和0.060),未达到统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Retrospective study of a prospective multicenter database. OBJECTIVE: The purpose of this study was to identify predictors of lower total surgery costs at 3 years for adult spinal deformity (ASD) patients. SUMMARY OF BACKGROUND DATA: ASD surgery involves complex deformity correction. METHODS: Inclusion criteria: surgical ASD (scoliosis ≥20°, sagittal vertical axis [SVA] ≥5 cm, pelvic tilt ≥25°, or thoracic kyphosis ≥60°) patients >18 years. Total costs for surgery were calculated using the PearlDiver database. Cost per quality-adjusted life year was assessed. A Conditional Variable Importance Table used nonreplacement sampling set of 20,000 Conditional Inference trees to identify top factors associated with lower cost surgery for low (LSVA), moderate (MSVA), and high (HSVA) SRS Schwab SVA grades. RESULTS: Three hundred sixtee of 322 ASD patients met inclusion criteria. At 3-year follow up, the potential cost of ASD surgery ranged from $57,606.88 to $116,312.54. The average costs of surgery at 3 years was found to be $72,947.87, with no significant difference in costs between deformity groups (P > 0.05). There were 152 LSVA patients, 53 MSVA patients, and 111 HSVA patients. For all patients, the top predictors of lower costs were frailty scores <0.19, baseline (BL) SRS Activity >1.5, BL Oswestry Disability Index <50 (all P < 0.05). For LSVA patients, no history of osteoporosis, SRS Activity scores >1.5, age <64, were the top predictors of lower costs (all P < 0.05). Among MSVA patients, ASD invasiveness scores <94.16, no past history of cancer, and frailty scores <0.3 trended toward lower total costs (P = 0.071, P = 0.210). For HSVA, no history of smoking and body mass index <27.8 trended toward lower costs (both P = 0.060). CONCLUSION: ASD surgery has the potential for improved cost efficiency, as costs ranged from $57,606.88 to $116,312.54. Predictors of lower costs included higher BL SRS activity, decreased frailty, and not having depression. Additionally, predictors of lower costs were identified for different BL deformity profiles, allowing for the optimization of cost efficiency for all patients.Level of Evidence: 3.
引用
- Passias PG, Brown AE, Bortz C, et al. Increasing Cost Efficiency in Adult Spinal Deformity Surgery: Identifying Predictors of Lower Total Costs. Spine (Phila Pa 1976). 2022. PMID: 34392276. doi:10.1097/BRS.0000000000004201
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。